在人类乳腺癌细胞中,EIF4A3通过CDC5L上调促进细胞增殖
Miao Zhang1,2, Yuchen Xie3, Shaoran Song4
1Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, P.R. China.
Journal of Cancer
|March 17, 2025
概括
翻译启动因子EIF4A3通过调节CDC5L.L.来促进乳腺癌的生长. 这个EIF4A3-CDC5L轴加速癌细胞的增殖,提供了对乳腺癌恶性病变的见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌仍然是全球女性的重大健康问题.
- 翻译启动因子EIF4A3与瘤发育有关,但其在乳腺癌中的确切作用尚未完全理解.
研究的目的:
- 阐明EIF4A3促进乳腺癌恶性病变的分子机制.
- 研究EIF4A3在乳腺癌进展中的体内和体外功能.
主要方法:
- 在乳腺癌组织中对EIF4A3表达的定量分析.
- RNA免疫沉测序 (RIP-seq) 和RIP-定量PCR (RIP-RT-qPCR) 用于识别EIF4A3的目标.
- 在中使用catRAPID进行预测,以确定结合部位.
主要成果:
- 在乳腺癌中,EIF4A3表达显著上调.
- 过度表达EIF4A3可以增强乳腺癌细胞的扩散.
- EIF4A3直接与CDC5LmRNA结合,影响其表达并作为下游效应因子.
结论:
- EIF4A3-CDC5L轴被确定为乳腺癌细胞增殖的关键驱动因素.
- 这项研究提供了对EIF4A3在乳腺癌进展中的作用的机制性理解.
- 这些发现为乳腺癌治疗提供了潜在的治疗点.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K


